Table 2. Neurons and SGCs responding to glutamate or selective agonists with or without specific antagonists using calcium imaging.
Agonist vs. Antagonist+Agonist | Responding Neurons#/total N (%) | Δ 340/380 ratio neurons | Responding SGCs#/total N (%) | Δ 340/380 ratio SGCs |
Glutamate | 51/56 (91) | 12.7±1.8*** | 34/40 (85) | 7.81±1*** |
AMPA vs. CNQX+AMPA | 25/29 (86) | 9.8±2.1 vs. 1.0±0.8*** | 35/37 (95) | 11.9±1.7 vs. 1.6±0.8*** |
NMDA vs. APV+NMDA | 12/23 (52) | 4.8±0.9 vs. 1.3±0.9** | 7/14 (50) | 11.1±3.7 vs. 0.9±0.9** |
KA vs. UBP310+ KA | 11/13 (85) | 23.8±8.6 vs. 0.3±1.4** | 22/24 (92) | 24.8±3.1 vs. 3.6±1.2** |
DHPG vs. AP3+ DHPG | 20/21 (95) | 9.4±2.0 vs. 1.4±1.1*** | 5/6 (83) | 12.2±1.8 vs. 2.1±2.3** |
Mean ± S.E.M.
P<0.01;
P<0.001.